Target intelligence / Profile preview

Engineered inhibitory muscarinic acetylcholine receptor M4 (hM4Di) (hM4Di)

Target
hM4Di
Molecular classification
G protein-coupled receptor, Muscarinic acetylcholine receptor (modified), Chemogenetic tool
01

Overview

The engineered inhibitory DREADD (Designer Receptor Exclusively Activated by Designer Drugs) receptor, specifically the hM4Di variant, is a modified human muscarinic M4 receptor (CHRM4) engineered to lose affinity for its endogenous ligand, acetylcholine, while gaining high affinity for synthetic, otherwise inert designer ligands (Armbruster et al., 2007, PNAS). When expressed in the inhibitory neurons of the caudate nucleus—primarily GABAergic medium spiny neurons—this receptor serves as a chemogenetic tool to selectively and reversibly silence neuronal activity (Nagai et al., 2016, Nature Communications). Activation of hM4Di by ligands such as clozapine N-oxide (CNO) or the high-potency agonist deschloroclozapine (DCZ) induces the Gi protein-coupled signaling pathway, which inhibits adenylyl cyclase and opens G protein-coupled inwardly-rectifying potassium (GIRK) channels, leading to membrane hyperpolarization (Roth, 2016, Neuron). This targeted inhibition allows researchers and clinicians to modulate the basal ganglia circuitry, which is critical for motor control, habit formation, and reward-seeking behavior (Nagai et al., 2020, Nature Communications). Therapeutically, this approach is being explored for treating neurological and psychiatric conditions characterized by neuronal overactivity or circuit dysfunction, such as Parkinson's disease, dystonia, and drug addiction (Wess et al., 2013, Trends in Pharmacological Sciences). However, challenges remain regarding the metabolic conversion of CNO to clozapine in primates and the potential immunogenicity of the viral vectors used for receptor delivery (Gomez et al., 2017, Science).

Other names
hM4D(Gi)Inhibitory DREADDGi-DREADDDesigner receptor exclusively activated by designer drugs
02

Mechanism of action

Agonist-induced activation of the Gi signaling pathway, leading to the inhibition of adenylyl cyclase, reduction of cAMP levels, and activation of G protein-coupled inwardly-rectifying potassium (GIRK) channels, which results in neuronal hyperpolarization and suppression of action potential firing.

03

Biological functions

Signal transductionNeuronal inhibitionHyperpolarization of cell membraneModulation of neurotransmitter release
04

Disease associations

Parkinson's diseaseHuntington's diseaseDystoniaSubstance use disorder (Addiction)Obsessive-compulsive disorder (OCD)
05

Safety considerations

Metabolic conversion of CNO to clozapine in primatesPotential for viral vector-induced inflammatory responseOff-target binding of designer ligands at high concentrationsLong-term physiological changes from chronic neuronal silencing
06

Interacting drugs

Clozapine N-oxide (CNO)

4 more in the full profile.

07

Biomarkers

[11C]Deschloroclozapine (DCZ) PET imaging[11C]Clozapine PET imagingc-Fos immunoreactivity

Beyond the preview

Go deeper on Engineered inhibitory muscarinic acetylcholine receptor M4 (hM4Di) (hM4Di).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Engineered inhibitory muscarinic acetylcholine receptor M4 (hM4Di) (hM4Di).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call